Trade Report: The Zacks: CRH Medical Corp (CRHM) Given $6.35 Consensus Target Price by Analysts

The Zacks: CRH Medical Corp (CRHM) Given $6.35 Consensus Target Price by Analysts

Shares of CRH Medical Corp (NASDAQ:CRHM) have earned a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Analysts have set a twelve-month consensus price objective of $6.35 for the company and are forecasting that the company will post $0.05 earnings per share for the current quarter, according to Zacks. Zacks has also assigned CRH Medical Corp an industry rank of 111 out of 265 based on the ratings given to related companies.

Several equities analysts recently weighed in on CRHM shares. Canaccord Genuity reaffirmed a “buy” rating on shares of CRH Medical Corp in a research note on Monday, July 11th. Zacks Investment Research cut shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a research note on Monday, September 5th. RBC Capital Markets reaffirmed an “outperform” rating and set a $6.50 target price on shares of CRH Medical Corp in a research note on Saturday, October 8th. Finally, CIBC reaffirmed an “outperform” rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th.

Several institutional investors have recently modified their holdings of the company. Sentry Investments Corp. boosted its position in shares of CRH Medical Corp by 1.9% in the second quarter. Sentry Investments Corp. now owns 386,300 shares of the company’s stock worth $1,943,000 after buying an additional 7,300 shares during the last quarter. TFS Capital LLC acquired a new position in shares of CRH Medical Corp during the second quarter worth approximately $138,000. Counsel Portfolio Services Inc. acquired a new position in shares of CRH Medical Corp during the second quarter worth approximately $485,000. Ativo Capital Management LLC acquired a new position in shares of CRH Medical Corp during the second quarter worth approximately $1,076,000. Finally, Bank of Montreal Can acquired a new position in shares of CRH Medical Corp during the second quarter worth approximately $1,258,000.

Shares of CRH Medical Corp (NASDAQ:CRHM) traded up 0.69% during trading on Friday, hitting $4.40. 12,986 shares of the company traded hands. CRH Medical Corp has a 52 week low of $2.15 and a 52 week high of $4.72. The company has a 50 day moving average price of $3.88 and a 200 day moving average price of $3.58.

CRH Medical Corp Company Profile

CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.

Related posts

Leave a Comment